Cargando…
The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer
Over 300,000 patients develop squamous cell carcinoma of the head and neck (HNSCC) worldwide with 25-30% of patients ultimately dying from their disease. Currently, molecular biomarkers are not used in HNSCC but several genes have been identified including mutant TP53 (mutp53) Our recent work has id...
Autores principales: | Coaxum, Sonya D., Tiedeken, Jessica, Garrett-Mayer, Elizabeth, Myers, Jeffrey, Rosenzweig, Steven A., Neskey, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410280/ https://www.ncbi.nlm.nih.gov/pubmed/28160562 http://dx.doi.org/10.18632/oncotarget.14967 |
Ejemplares similares
-
Vimentin and Non-Muscle Myosin IIA are Members of the Neural Precursor Cell Expressed Developmentally Down-Regulated 9 (NEDD9) Interactome in Head and Neck Squamous Cell Carcinoma Cells()
por: Semelakova, Martina, et al.
Publicado: (2018) -
Non-Muscle Myosin IIa Heavy Chain Links Squamous-Cell Carcinoma of the Head and Neck to the DNA Damage Response
por: Raleigh, David R., et al.
Publicado: (2014) -
NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma
por: Grauzam, Stéphane, et al.
Publicado: (2018) -
The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
por: Fritsche, Marie Kristin, et al.
Publicado: (2017) -
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
por: Alanazi, Samar M., et al.
Publicado: (2023)